• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Limitations of acetylcholinesterase inhibitor therapy for Alzheimer's disease.

作者信息

Yang Guang, Wu Jiawen, Lei Hang, Hui Yining

机构信息

Department of Neurology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan.

Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan.

出版信息

Int J Surg. 2024 Sep 1;110(9):5852-5853. doi: 10.1097/JS9.0000000000001611.

DOI:10.1097/JS9.0000000000001611
PMID:38728857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11392090/
Abstract
摘要

相似文献

1
Letter to the Editor: Limitations of acetylcholinesterase inhibitor therapy for Alzheimer's disease.致编辑的信：用于治疗阿尔茨海默病的乙酰胆碱酯酶抑制剂疗法的局限性
Int J Surg. 2024 Sep 1;110(9):5852-5853. doi: 10.1097/JS9.0000000000001611.
2
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.用于治疗阿尔茨海默病的胆碱酯酶抑制剂：药理作用与临床疗效之间的关系。
Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004.
3
Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?在阿尔茨海默病的治疗中使用乙酰胆碱酯酶抑制剂有理论依据吗？
Eur J Pharmacol. 1998 Apr 3;346(1):1-13. doi: 10.1016/s0014-2999(98)00093-4.
4
Acetylcholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的乙酰胆碱酯酶抑制剂
BMJ. 1999 Mar 6;318(7184):615-6. doi: 10.1136/bmj.318.7184.615.
5
[The use of acetylcholinesterase inhibitors in Alzheimer's disease].
Przegl Lek. 2001;58 Suppl 3:2-6.
6
[Treatment of Alzheimer's disease with acetylcholinesterase inhibitors].
Rev Neurol (Paris). 2008 Apr;164 Spec No 2:F107.
7
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.使用卡巴拉汀治疗的阿尔茨海默病患者使用抗精神病药物的风险。
Drugs Aging. 2004;21(6):395-403. doi: 10.2165/00002512-200421060-00004.
8
Acetylcholinesterase inhibitors in Alzheimer's disease.用于治疗阿尔茨海默病的乙酰胆碱酯酶抑制剂
Br J Clin Pharmacol. 1999 Oct;48(4):471-80. doi: 10.1046/j.1365-2125.1999.00026.x.
9
Letter to the editor concerning the pharmacological management of behavioral disturbances in patients with Alzheimer's disease.
Expert Opin Pharmacother. 2020 Dec;21(18):2325-2326. doi: 10.1080/14656566.2020.1808354. Epub 2020 Aug 18.
10
Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?阿尔茨海默病中的胆碱酯酶抑制作用：特异性是答案所在吗？
J Alzheimers Dis. 2014;42(2):379-84. doi: 10.3233/JAD-140219.

本文引用的文献

1
The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.胆碱酯酶抑制剂在改善阿尔茨海默病患者神经精神和功能评估评分方面的价值：基于安慰剂对照 RCT 的系统评价和荟萃分析。
Int J Surg. 2024 Jun 1;110(6):3937-3945. doi: 10.1097/JS9.0000000000001381.
2
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease.重新审视乙酰胆碱酯酶抑制剂。对阿尔茨海默病上市后研究的叙述性综述。
Aging Clin Exp Res. 2024 Feb 7;36(1):23. doi: 10.1007/s40520-023-02675-6.
3
Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis.揭示聚集物自噬在阿尔茨海默病发展中的作用：机器学习分析对诊断和治疗方法的启示。
Curr Alzheimer Res. 2023;20(9):618-635. doi: 10.2174/0115672050280894231214063023.
4
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer's Disease and Future Perspectives.胆碱酯酶抑制剂的神经保护作用：阿尔茨海默病治疗的现状与未来展望
J Alzheimers Dis Rep. 2022 Apr 18;6(1):177-193. doi: 10.3233/ADR-210061. eCollection 2022.